Clinion is an AI-enabled eClinical Platform consisting of an Electronic Data Capture (EDC), Randomisation and Trial Supply Management (IWRS/RTSM), Patient Reported Outcomes (eCOA) and Clinical Trial Management Systems (CTMS).
We envisage Clinion to be the AI-enabled eClinical platform of choice for small and medium CROs, and academic and pharmaceutical organisations in the global market.
Clinion eCOA have been recognized as a finalist in the 2021 Citeline Awards for Best Patient-Facing Technology initiative.
Clinion AI-enabled eClinical Platform has won the prestigious 2020 HYSEA Award for the category of Best Software Product – Mature Stage.
At Clinion, we are working hard on a solid pipeline of product improvements
Predictive analytics with risk based monitoring
Our vision is to incorporate AI and automation at every step of the clinical trial process. Predictive analytics to help with patient recruitment, risk based site monitoring, adverse event management, and improved data management.
Clinion’s Mobile app (iOS and android) is in its last stage of development and it will enable our customers to deploy study eCRF on mobile phones, aiding remote study sites in capturing data offline.
Smart and automated eTMF to reduce manual labor.
Virtual clinical trials
Clinion’s AI-enabled eClinical Platform with EDC, RTSM and ePRO makes it an ideal fit for conducting clinical trials remotely.
Located in Hyderabad, India, Clinion’s team is led by pharmaceutical industry veterans and supported by clinical research experts and enterprise software engineers. We have more than 30 people working across departments including product development, research, software engineering, sales, QA and technical support.